Hydrogen Gas / IFN-γ Cancer Research Results

H2, Hydrogen Gas: Click to Expand ⟱

Features:

Hydrogen Gas, Powerful Antioxidant
Mechanistically, H₂ is most defensibly framed as a selective antioxidant + anti-inflammatory signaling modulator (often via Nrf2↑ and NF-κB↓ / NLRP3↓), with strongest clinical relevance in oncology being reduction of treatment toxicities (radiation/CCRT side-effects), with mixed/early evidence for direct anticancer effects.

1.Antioxidant and Nrf2/ARE Pathway: activate Nrf2, which induces antioxidant enzymes.
2.NF-κB Pathway: reported to inhibit NF-κB activation, thereby reducing inflammatory cytokine production
3.Mitochondrial Apoptosis Pathway
4.MAPK (Mitogen-Activated Protein Kinases) Pathway
5.PI3K/Akt/mTOR Pathway
6.Inflammatory Cytokine Signaling: Reducing cytokines (such as IL-6, TNF-α)
7.p53 Pathway
8.Autophagy Pathways: might regulate autophagy, (dual roles in cancer)

Example unit sometimes used in studies
Example Canadian Supplier

Hydrogen gas can be generated in small amount by hydrogenase of certain members of the human gastrointestinal tract microbiota from unabsorbed carbohydrates in the intestine through degradation and metabolism, which then is partially diffused into blood flow and released and detected in exhaled breath, indicating its potential to serve as a biomarker.

Many studies have shown that H2 therapy can reduce oxidative stress. This, however, contradicts radiation therapy and chemotherapy, in which ROS are required to induce apoptosis and combat cancer. Yet many studies show chemoprotective and radioprotective and some even show chemosentizing
Nevertheless there are some papers claiming ROS ↑ for cancer cells

Hydrogen Gas in Water is also used.
- the amount of H2 dissolved in solutions is limited: up to 0.8 mM (1.6 mg/L) H2 can be dissolved in water under atmospheric pressure at room temperature

Rank	Pathway / Axis	Cancer / Tumor Context	Normal Tissue Context	TSF	Primary Effect	Notes / Interpretation
1	Selective ROS/RNS buffering (•OH, ONOO− emphasis)	Oxidative damage tone ↓ (context-dependent)	Radiation/chemo oxidative injury ↓	P, R	Rapid cytoprotection	Landmark work proposes H2 selectively reduces highly reactive species (e.g., hydroxyl radical) rather than globally suppressing signaling ROS. Treat as "selective antioxidant" rather than broad ROS quencher.
2	Nrf2 antioxidant response (Keap1/Nrf2; SOD/GPx/GSH systems)	Stress adaptation modulation (context-dependent)	Nrf2 ↑; endogenous antioxidant enzymes ↑	R, G	Endogenous antioxidant upshift	Multiple reviews describe H2 as engaging Nrf2-linked programs and increasing antioxidant enzyme activity; direction in tumors is model-specific and should not be oversold as uniformly anti-tumor.
3	NF-κB inflammatory transcription	Inflammatory/pro-survival transcription ↓ (context)	Inflammation ↓ (tissue protective)	R, G	Anti-inflammatory signaling	Commonly reported downstream of redox modulation: reduced NF-κB activity and reduced inflammatory cytokine outputs.
4	NLRP3 inflammasome (priming/activation)	Inflammasome signaling ↓ (context)	NLRP3 activation ↓; tissue injury signaling ↓	R, G	Inflammasome dampening	Often described as part of an antioxidant–anti-inflammatory synergy (Nrf2↑ with NF-κB/NLRP3↓). Use "reported" language.
5	Mitochondrial protection / mitochondrial ROS	Mito-stress tone ↓ (context)	Mitochondrial function preserved; oxidative injury ↓	R, G	Bioenergetic stabilization	Frequently reported as reduced mitochondrial oxidative injury and improved cellular resilience in injury/inflammation models.
6	Radiation/CCRT toxicity mitigation (clinical relevance)	Adjunct use: may reduce acute radiation toxicities without obvious loss of tumor control (early evidence)	Mucositis/dermatitis/inflammation severity ↓ (reported)	G	Supportive care	Clinical studies report feasibility/safety and reduced radiotherapy-related toxicities in selected settings; treat as supportive/adjunct, not standalone anti-cancer therapy.
7	Apoptosis / proliferation control	Mixed reports: apoptosis ↑ or neutral depending on model	Often anti-apoptotic in injury models	G	Context-dependent cell fate shift	Unlike classic cytotoxins, H2 effects on apoptosis/proliferation are not uniform; keep as model-dependent and secondary.
8	Clinical safety signal (inhalation studies)	—	Generally well tolerated at low concentrations in studied settings	—	Translation constraint / safety framing	Human safety studies exist for low-concentration inhalation; practical use must be medical-grade and safety-controlled due to flammability risk.

Time-Scale Flag (TSF): P / R / G

P: 0–30 min (direct chemical/rapid signaling effects)
R: 30 min–3 hr (acute redox + inflammatory signaling shifts)
G: >3 hr (gene-regulatory adaptation and phenotype-level outcomes)

IFN-γ, Interferon-γ: Click to Expand ⟱

Source:

Type:

Plays a key role in activation of cellular immunity and subsequently, stimulation of antitumor immune-response. Based on its cytostatic, pro-apoptotic and antiproliferative functions, IFN-γ is considered potentially useful for adjuvant immunotherapy for different types of cancer.
Moreover, it IFN-γ may inhibit angiogenesis in tumor tissue, induce regulatory T-cell apoptosis, and/or stimulate the activity of M1 proinflammatory macrophages to overcome tumor progression.
However, the current understanding of the roles of IFN-γ in the tumor microenvironment (TME) may be misleading in terms of its clinical application.

IFN-γ is often expressed in the tumor microenvironment, particularly in response to immune cell infiltration. Its expression can be influenced by the presence of tumor-infiltrating lymphocytes (TILs) and other immune cells.
High levels of IFN-γ are typically associated with a Th1 immune response, which is generally considered beneficial for anti-tumor immunity.

Tumor Suppression:
In many cases, IFN-γ has tumor-suppressive effects, as it can inhibit tumor cell proliferation and induce apoptosis in certain cancer types.

Scientific Papers found: Click to Expand⟱

4346-

H2,

Medical Application of Hydrogen in Hematological Diseases

Review,

NA,

*AntiAg↑, *TNF-α↓, *IL6↓, *IFN-γ↓, *NF-kB↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

Migration ⓘ

AntiAg↑, 1,

Immune & Inflammatory Signaling ⓘ

IFN-γ↓, 1, IL6↓, 1, NF-kB↓, 1, TNF-α↓, 1,

Clinical Biomarkers ⓘ

IL6↓, 1,
Total Targets: 6

Scientific Paper Hit Count for: IFN-γ, Interferon-γ

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells